التفاصيل البيبلوغرافية
| العنوان: |
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma |
| المؤلفون: |
Pouleau, Blandine, Estoppey, Carole, Suere, Perrine, Nallet, Emilie, Laurendon, Amélie, Monney, Thierry, Pais Ferreira, Daniela, Drake, Adam, Carretero-Iglesia, Laura, Macoin, Julie, Berret, Jérémy, Pihlgren, Maria, Doucey, Marie-Agnès, Gudi, Girish S., Menon, Vinu, Udupa, Venkatesha, Maiti, Abhishek, Borthakur, Gautam, Srivastava, Ankita, Blein, Stanislas, Mbow, M. Lamine, Matthes, Thomas, Kaya, Zeynep, Edwards, Claire M., Edwards, James R., Menoret, Emmanuelle, Kervoëlen, Charlotte, Pellat-Deceunynck, Catherine, Moreau, Philippe, Zhukovsky, Eugene, Perro, Mario, Chimen, Myriam |
| المصدر: |
Blood; July 2023, Vol. 142 Issue: 3 p260-273, 14p |
| مستخلص: |
•ISB 1342 exhibits potent killing of primary MM cells and MM cell lines with low sensitivity to daratumumab.•ISB 1342 induced complete MM tumor eradication in 2 in vivo mouse models. |
| قاعدة البيانات: |
Supplemental Index |
